Hyperterm intraperitoneal kemoterapi ved den primære operation for gastrointestinal cancer

Thea Helene Degett; Hans-Christian Pommergaard; Ismail Gögenur

Hyperterm intraperitoneal kemoterapi ved den primære operation for gastrointestinal cancer

Translated title of the contribution: Hyperthermic intraperitoneal chemotherapy at the primary gastrointestinal cancer operation

Thea Helene Degett, Hans-Christian Pommergaard, Ismail Gögenur

Department of Clinical Medicine

1 Citation (Scopus)

Abstract

Up to 20% of the patients who undergo radical surgery for colorectal cancer experience recurrence. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery have shown to be effective treatment of peritoneal carcinomatosis. HIPEC administered at the primary operation in high-risk patients may also be effective in preventing peritoneal carcinomatosis and improve survival in patients with advanced gastrointestinal cancer.

Translated title of the contribution	Hyperthermic intraperitoneal chemotherapy at the primary gastrointestinal cancer operation
Original language	Danish
Article number	V06160454
Journal	Ugeskrift for Læger
Volume	179
Number of pages	4
ISSN	0041-5782
Publication status	Published - 1 Jun 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://ugeskriftet.dk/videnskab/hyperterm-intraperitoneal-kemoterapi-ved-den-primaere-operation-gastrointestinal-cancer

Cite this

@article{cfb6ccd692c14ad39483870809f7edcc,

title = "Hyperterm intraperitoneal kemoterapi ved den prim{\ae}re operation for gastrointestinal cancer",

abstract = "Up to 20% of the patients who undergo radical surgery for colorectal cancer experience recurrence. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery have shown to be effective treatment of peritoneal carcinomatosis. HIPEC administered at the primary operation in high-risk patients may also be effective in preventing peritoneal carcinomatosis and improve survival in patients with advanced gastrointestinal cancer.",

author = "Degett, {Thea Helene} and Hans-Christian Pommergaard and Ismail G{\"o}genur",

year = "2017",

month = jun,

day = "1",

language = "Dansk",

volume = "179",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

}

TY - JOUR

T1 - Hyperterm intraperitoneal kemoterapi ved den primære operation for gastrointestinal cancer

AU - Degett, Thea Helene

AU - Pommergaard, Hans-Christian

AU - Gögenur, Ismail

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Up to 20% of the patients who undergo radical surgery for colorectal cancer experience recurrence. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery have shown to be effective treatment of peritoneal carcinomatosis. HIPEC administered at the primary operation in high-risk patients may also be effective in preventing peritoneal carcinomatosis and improve survival in patients with advanced gastrointestinal cancer.

AB - Up to 20% of the patients who undergo radical surgery for colorectal cancer experience recurrence. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery have shown to be effective treatment of peritoneal carcinomatosis. HIPEC administered at the primary operation in high-risk patients may also be effective in preventing peritoneal carcinomatosis and improve survival in patients with advanced gastrointestinal cancer.

M3 - Tidsskriftartikel

C2 - 28330549

SN - 0041-5782

VL - 179

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

M1 - V06160454

ER -

Hyperterm intraperitoneal kemoterapi ved den primære operation for gastrointestinal cancer

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this